Enhancing Pharma Manufacturing Efficiency through Advanced Automation

In today's fast-paced pharmaceutical industry, efficiency plays a critical role in meeting the increasing demands for drugs and medical products. To achieve optimal efficiency, pharmaceutical manufacturers are turning to advanced automation solutions. Advanced automation encompasses cutting-edge technologies like robotics, artificial...

1 year ago
Biomanufacturing,Blog

Enhancing Pharma Manufacturing Efficiency through Advanced Automation

In today's fast-paced pharmaceutical industry, efficiency plays a critical role in meeting the increasing demands for drugs and medical products. To achieve optimal efficiency, pharmaceutical manufacturers are turning to advanced automation solutions. Advanced automation encompasses cutting-edge technologies like robotics, artificial...

1 year ago

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

1 year ago
R&D,Regulatory Affairs,Blog

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

1 year ago

COVID’s Impact on Innovations in Regulatory Affairs

While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...

3 years ago
Bioprocess,Regulatory Affairs,News

COVID’s Impact on Innovations in Regulatory Affairs

While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...

3 years ago

Challenges and Opportunities in Pharmaceutical Manufacturing

The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....

3 years ago
Biomanufacturing,Biology

Challenges and Opportunities in Pharmaceutical Manufacturing

The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....

3 years ago

Latest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease

Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...

3 years ago
CGT,Clinical Development,News

Latest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease

Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...

3 years ago

Strategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi

In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....

3 years ago
R&D,Bioprocess,Biology,News

Strategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi

In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....

3 years ago

Evaluating Advancements in Drug Discovery

Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...

3 years ago
Bioprocess,Biology,News

Evaluating Advancements in Drug Discovery

Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...

3 years ago

Aseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing

In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...

3 years ago
Oncology,Biomanufacturing

Aseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing

In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...

3 years ago

Emerging Therapeutics in Translational Medicine: Nanotechnology

Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...

3 years ago
Bioinformatics,Biomanufacturing,Biology,News

Emerging Therapeutics in Translational Medicine: Nanotechnology

Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...

3 years ago

How Has COVID Affected Pharmaceutical Manufacturing?

In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...

4 years ago
Biomanufacturing,Biology,News

How Has COVID Affected Pharmaceutical Manufacturing?

In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...

4 years ago